Emerging research on molecular hydrogen reveals its potential as an adjunctive cancer therapy. It works by selectively targeting and neutralizing free radicals, thereby reducing oxidative stress which is linked to cancer progression. Studies have shown that hydrogen can attenuate the side effects of chemotherapy and radiotherapy, such as reducing oxidative damage without compromising treatment efficacy. Its anti-inflammatory properties further contribute to its therapeutic potential, offering a promising, non-toxic option to enhance cancer treatment outcomes and improve patient quality of life. *For education only — not medical advice.

KongX , LuT, LuY-Y, YinZ and XuK

Zhang X, Tao G, Zhao Y, et al.

Xu KC, Chen JB, Kong XF, et al.

Zhu B, Cui H, Xu W.

Zhang X, Tao G, Zhao Y, et al.

Carrie Decker, ND

Chen JB, Kong XF, Mu F, Lu TY, Lu YY, Xu KC.

Chu J, Gao J, Wang J, et al.

Chen J, Kong X, Mu F, Lu T, Du D, Xu K

Hu Q, Zhou Y, Wu S, Wu W, Deng Y, Shao A.

Chen JB, Kong XF, Qian W, et al

Chen JB, Kong XF, Qian W, et al.

Hirano SI, Aoki Y, Li XK, Ichimaru N, Takahara S, Takefuji Y.

Hirano S, Yamamoto H, Ichikawa Y, Sato B, Takefuji Y, Satoh F.

Chen JB, Lu YY, Xu KC.

Mohd Noor MNZ, Alauddin AS, Wong YH, et al

Meng J, Yu P, Jiang H, et al

Tian Y, Zhang Y, Wang Y, et al

Zhou P, Lin B, Wang P, et al

Yang Y, Zhu Y, Xi X.

Yang Q, Ji G, Pan R, Zhao Y, Yan P